TFS Capital’s Boston Scientific BSX Stock Holding History

TFS Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,346	Closed	-$230K	–	968
2014 Q4	$230K	Buy	+17,346	New	+$222K	0.02%	789

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

TFS Capital's BSX Position: Q1 2015 in Review

TFS Capital sold out of Boston Scientific (BSX) in Q1 2015, closing a stake of 17,346 shares — an estimated $230K sold.

TFS Capital first reported a position in BSX in Q4 2014 and held it in 1 quarter. The position peaked at $230K in Q4 2014. 470 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

TFS Capital reported no remaining Boston Scientific position as of Q1 2015 after selling out during the quarter.
TFS Capital sold 17,346 Boston Scientific shares in Q1 2015, an estimated $230K.
TFS Capital first reported a position in Boston Scientific in Q4 2014 and held it in 1 quarter.
TFS Capital's Boston Scientific position peaked at $230K in Q4 2014.
470 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on TFS Capital's 13F filing for Q1 2015, filed 29 Apr 2015.